The fact that GLUT4 expression is not reduced in those with insulin resistance, such as in the obese and T2DM [6, 7], suggests that the major underlying defects in this condition are likely to lie in the insulin signal transduction pathways and/or the translocation of GLUT4 to the plasma membrane in skeletal muscle. The gene discussed is INS; the disease is type 2 diabetes mellitus.